APR 13, 2021 8:00 AM PDT

The "Unexpected" Reason Why COVID Antivirals Don't Work

WRITTEN BY: Tara Fernandez

Purdue University researchers have made a breakthrough finding that could explain why the disease is so hard to manage therapeutically. In what was described as a surprising discovery, they found that a specific immune pathway activated in the lung tissue during COVID infection contributes to hyper-inflammation in severe cases, rendering standard antivirals ineffective.

Since the beginning of the pandemic, scientists have been scrambling to identify antiviral drugs to treat COVID patients with severe and life-threatening symptoms. Unfortunately, until now, this search has dug up very few viable options. Antivirals such as Remdesivir and Ruxolitinib are notoriously ineffective at treating COVID patients.

To understand why these drugs fall short, Purdue University computer science expert Majid Kazemian and colleagues took a closer look at the gene expression fingerprints left by SARS-CoV-2 infections. The team made the unexpected observation that small immune proteins, typically synthesized by the liver, were being produced in the fine structures of the lung known as alveoli. These proteins, part of the immune complement system, normally help the antibodies combat infectious pathogens.

“We observed that SARS-CoV2 infection of these lung cells causes expression of an activated complement system in an unprecedented way,” explained Kazemian. 

“This was completely unexpected to us because we were not thinking about activation of this system inside the cells, or at least not lung cells. We typically think of the complement source as the liver.”

However, instead of protecting against the coronavirus, complement activation in the lung triggers uncontrolled and detrimental tissue hyper-inflammation, a trademark symptom of severe COVID-19.

These findings provide evidence for why targeting inflammation outside the lungs has been disappointing so far. Instead, a more targeted approach that inhibits the expression and activation of complement proteins in lung cells could yield better results. For example, the researchers found that pairing Remdesivir with Ruxolitinib inhibited the complement response much more effectively than a monotherapy of the drugs independently, using an in vitro model of alveolar cells.

Despite the promising preliminary data, follow-up experiments are needed to determine whether such drug combos would work well in patients. 

 


Sources: Science Immunology, Purdue University.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 17, 2020
Immunology
A Peanut a Day Keeps Allergies Away
DEC 17, 2020
A Peanut a Day Keeps Allergies Away
Canadian researchers have made a breakthrough for children with peanut allergies: immunotherapy that when taken daily fo ...
DEC 25, 2020
Immunology
A High-Fat Diet Starves Immune Cells, Tumor Growth Goes Unchecked
DEC 25, 2020
A High-Fat Diet Starves Immune Cells, Tumor Growth Goes Unchecked
  Sitting down to enjoy an indulgent Christmas feast? A recent study in mice by Harvard Medicine scientists found t ...
JAN 06, 2021
Immunology
Probiotic Boosters Are Lifesavers for Preterm Babies
JAN 06, 2021
Probiotic Boosters Are Lifesavers for Preterm Babies
When administered shortly after birth, a recent study has found that the supplementation combo of probiotics and prebiot ...
APR 20, 2021
Immunology
Scientists Map the Genetic Landscape of COVID Infections
APR 20, 2021
Scientists Map the Genetic Landscape of COVID Infections
Scientists have identified 65 human immune genes activated during SARS-CoV-2 infection. This finding provides valuable i ...
APR 28, 2021
Cell & Molecular Biology
Learning More About the Sugars That Mediate Immune Interactions
APR 28, 2021
Learning More About the Sugars That Mediate Immune Interactions
Sugar is something sweet to add to your food, but just like fat, different types of sugars play important roles in biolo ...
MAY 10, 2021
Coronavirus
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
MAY 10, 2021
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
The pandemic virus SARS-CoV-2 has changed the world in devastating ways, taking hundreds of thousands of lives & new var ...
Loading Comments...